Dear Gmail team.
First, thank you for making it possible for me to see my unread mail - i sent you this idea some time ago, and i'm glad that you listened.
Second, I'm now somehow at 50% of my allocated capacity, and what i need is a way to filter my mails by attachment (which i can do!), but also order them from largest to smallest (which I can't do). Once i can order attachments by size, i can start deleting the big ones and free up more room! YAY!
m.
Thursday, September 22, 2011
Tuesday, September 20, 2011
On the topic of ontology evaluation
With only a cursory look at the literature pertaining to the evaluation of ontologies, I already get the feeling that the current measures completely miss the point. The answer doesn't lie in the syntax (format) or structure of the ontology (the number of classes and properties, subsumed classes, axioms, etc), but rather the
effectiveness of an ontology ( a representation of knowledge ) is in whether the semantics can be used for some task. So what we really want, is to focus on the nature of the task, and whether ontology provides a competitive advantage over other technologies.
Off the top of my head, here are some tasks:
- search/browse (most sites using GO, etc)
- text annotation (gopubmed)
- data normalization and structured queries - bio2rdf
- answering questions that require background knowledge e.g. across a yeast database.
- data integration (heterogeneous types of data; data
from different sources, of differing granular detail) (see my translational medicine paper)
- classification e.g. domains or chemicals
- prediction e.g. predicting phenotypes
Perhaps others can suggest some?
Labels:
application,
evaluation,
ontology,
task,
tools,
use case,
utility
Sunday, September 11, 2011
New Charter for the W3C Health Care and Life Sciences Interest Group
Last week, the World Wide Web Consortium (W3C) approved a new charter for its Health Care and Life Sciences Interest Group (HCLSIG), in which I (Carleton University) along with Charlie Mead (NIH CBIIT) and Vijay Bulusu (Pfizer) were selected as co-chairs. This new charter directs us to develop, advocate and support the use of Semantic Web technologies for translational medicine and its three enabling domains: life sciences, clinical research and health care. While the core HCLSIG values - simplicity, pragmatism, effectiveness - remain firmly in place, Charlie, Vijay and I hope to make subtle changes to the operational strategy such that our efforts become increasingly recognized as critical in conferences and boardrooms across the globe.
As always, the HCLSIG will create both prototype implementations that demonstrate the value of formalizing and sharing knowledge using Semantic Web technologies. We will marshal our efforts towards fulfilling compelling use cases that have intrinsic value to not just W3C members, but ideally to a larger number of outside benefactors. Thus, our experts will now develop these use cases such that a priori we have a clearer picture of the rationale of the project, its resources, milestones and deliverables, and ultimately, which organizations and communities will directly and indirectly benefit. Coupled with an effective dissemination strategy including leverage our combined social networks, we hope to maximize the impact of the work of our members in this emerging area of knowledge management.
As part of our dissemination strategy, we also intend to produce more member contributions that describe methods for basic and advanced tasks, in addition to publishing recommendations arising from consensus among our members. Such recommendations will endorse and specify the use of terminological resources in the long term context of semantic interoperability across the three core domains. Thus, participation in the HCLSIG will be critical for those wanting to advocate RDF-representations of data, OWL representations of ontologies, for the purposes of semantic annotation and large scale, semantic integration of biomedical data.
With that, we invite non-members to join the W3C and work with our strong compliment of experts in what will surely be an exciting and productive time over the next few years for the W3C HCLSIG.
As always, the HCLSIG will create both prototype implementations that demonstrate the value of formalizing and sharing knowledge using Semantic Web technologies. We will marshal our efforts towards fulfilling compelling use cases that have intrinsic value to not just W3C members, but ideally to a larger number of outside benefactors. Thus, our experts will now develop these use cases such that a priori we have a clearer picture of the rationale of the project, its resources, milestones and deliverables, and ultimately, which organizations and communities will directly and indirectly benefit. Coupled with an effective dissemination strategy including leverage our combined social networks, we hope to maximize the impact of the work of our members in this emerging area of knowledge management.
As part of our dissemination strategy, we also intend to produce more member contributions that describe methods for basic and advanced tasks, in addition to publishing recommendations arising from consensus among our members. Such recommendations will endorse and specify the use of terminological resources in the long term context of semantic interoperability across the three core domains. Thus, participation in the HCLSIG will be critical for those wanting to advocate RDF-representations of data, OWL representations of ontologies, for the purposes of semantic annotation and large scale, semantic integration of biomedical data.
With that, we invite non-members to join the W3C and work with our strong compliment of experts in what will surely be an exciting and productive time over the next few years for the W3C HCLSIG.
Labels:
hcls,
health care,
industry,
life sciences,
owl,
pharmaceuticals,
rdf,
semantic web,
w3c
Saturday, September 10, 2011
Bio2RDF: moving forward
Last week we held our first virtual meeting towards re-invigorating the Bio2RDF project with a significantly larger and vested community. From discussions, we plan to establish 3 focus groups around :
A. policy (information, governance, sustainability, outreach)
B. technical (architecture, infrastructure and RDFization)
C. social (user experience and social networking)
The next step then is for groups to:
1. identify and certify discussion leads (responsibilities: set meeting times and agenda, facilitate and encourage discussion among members, draft reports)
2. identify additional people to recruit from the wider community that would provide additional expertise (interested, but didn't attend the first? sign up now !)
3. extend and prioritize discussion items (what exactly will this group focus its efforts on in the short and long term)
4. identify and assign bite-sized tasks (so we can get things done one step at a time :)
5. collate results and present to the wider community
I suggest that groups self-organize a first meeting in the next two weeks to deal with items 1-4, and either meet again or use the Google documents to collaboratively report findings.
Finally, I'd like for us to hold another meeting with times that are much more accommodating for Europe + North America ;) Please fill the doodle poll (http://www.doodle.com/ fsuz6mgs5cztf2e2)
As always, feel free to contact me if you have any questions, and please sign up to the Bio2RDF mailing list for all future discussions.
Sunday, September 4, 2011
Scientific Publishing: We're not quite there yet...
I recall how discussions with Pascal Hitzler at ISWC2008 in Karlsruhe eventually led to the creation of a new journal: Semantic Web in 2009. It had most of the elements I wanted :
1- immediately availability of the manuscript
2- a transparent review process
3- a high standard of quality.
4- low cost of publication
The immediately availability of the manuscript is important because publishing in a peer-reviewed journals can often take more than 1 year - so this is problematic when making claims about who did what and when. A transparent review process is important to create an incentive to carefully formulate constructive reviews and weed out spurious reviews dealt under the veil of anonymity. In addition, we can establish the reviewer quality and reliability - important when asking for future review requests. Another other other aspect of open review is to enable the acknowledgement of reviewer contributions to improving the quality of the manuscript. In this respect, Semantic Web is stellar - it acknowledges the editors and the reviewers on the front page of the published manuscript.
One concern was whether reviewers would be sufficiently forthcoming about the failings of a paper such that it lead to the strong rejection of the manuscript. From all indications (see the paper that Pascal and Krzysztof wrote http://t.co/twDASAN9), the journal not only rejects a significant number of manuscripts that don't meet expectations for publication, but also does so in a constructive manner such that it invites authors to submit a revised manuscript with indicating how they have addressed the reviewer's comments. Indeed, this aspect of open review also means that it authors attempt to shop the failed manuscript to other journals, a simple web search should uncover the reviews associated with it. This saves precious editor and reviewer time and really pushes the authors to make substantial changes.
While this is all good, the major point of content is the business model. From any which way I look at it, I get the feeling that the tables are turned upside down. First you have the authors creating intellectual content, which they submit to a journal, and is reviewed by people who don't get paid to do so. The journal then turns around and tells the authors that if they want it freely available to the public, then the authors should cough up the money. This is ridiculous. Even a simple advertising based model could easily make a return on investment for articles of increasing impact. The other aspect is that the publisher needs to cover the costs of a print publication, but really, who reads print? I haven't for over 10 years now! In the case of the Journal, they exact a cost in typesetting, but we're used to doing this for our workshop and conference submissions - so we really don't need people to do this anymore. It would be nice to see a break down of costs for digital publishing systems today (perhaps you can point us to one).
So what is the business model of the modern scientific publisher? Well, i think it lies in aggregating and creating new content, whether editorials or comprehensive reviews, which give readers a viewpoint or summary of where the field is heading. Perhaps low-cost subscriptions (e.g. $100/yr) or pay per view ($5), one could recoup costs if the work is sufficiently meritorious. It's definitely time to think about the next evolution in scientific publishing.
Subscribe to:
Posts (Atom)